560 related articles for article (PubMed ID: 34731465)
1. Fighting COVID-19 with Artificial Intelligence.
Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
[TBL] [Abstract][Full Text] [Related]
2. The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective.
Zuo HL; Lin YC; Huang HY; Wang X; Tang Y; Hu YJ; Kong XJ; Chen QJ; Zhang YZ; Hong HC; Li J; Hu SY; Huang HD
Acta Pharmacol Sin; 2021 Jun; 42(6):845-847. PubMed ID: 33850275
[No Abstract] [Full Text] [Related]
3. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.
Floresta G; Zagni C; Gentile D; Patamia V; Rescifina A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328682
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence in COVID-19 drug repurposing.
Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
[TBL] [Abstract][Full Text] [Related]
5. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
Martinez MA
Front Immunol; 2021; 12():635371. PubMed ID: 33777024
[No Abstract] [Full Text] [Related]
6. Application of artificial intelligence and machine learning in drug repurposing.
Ghandikota SK; Jegga AG
Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
[TBL] [Abstract][Full Text] [Related]
7. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
[TBL] [Abstract][Full Text] [Related]
8. Indian contribution toward biomedical research and development in COVID-19: A systematic review.
Kaur H; Kaur M; Bhattacharyya A; Prajapat M; Thota P; Sarma P; Kumar S; Kaur G; Sharma S; Prakash A; Saifuddin PK; Medhi B
Indian J Pharmacol; 2021; 53(1):63-72. PubMed ID: 33976001
[TBL] [Abstract][Full Text] [Related]
9. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
[TBL] [Abstract][Full Text] [Related]
10. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.
Das G; Das T; Chowdhury N; Chatterjee D; Bagchi A; Ghosh Z
Genomics; 2021 Jan; 113(1 Pt 2):1129-1140. PubMed ID: 33189776
[TBL] [Abstract][Full Text] [Related]
11. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to watch in 2021.
Kaplon H; Reichert JM
MAbs; 2021; 13(1):1860476. PubMed ID: 33459118
[TBL] [Abstract][Full Text] [Related]
13. Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.
Esmail S; Danter W
Stem Cells Transl Med; 2021 Feb; 10(2):239-250. PubMed ID: 32961040
[TBL] [Abstract][Full Text] [Related]
14. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
Tayara H; Abdelbaky I; To Chong K
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
[TBL] [Abstract][Full Text] [Related]
15. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
Goel B; Bhardwaj N; Tripathi N; Jain SK
Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
[TBL] [Abstract][Full Text] [Related]
16. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
Debnath SK; Debnath M; Srivastava R; Omri A
Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
[TBL] [Abstract][Full Text] [Related]
17. Drugs against SARS-CoV-2: What do we know about their mode of action?
Valle C; Martin B; Touret F; Shannon A; Canard B; Guillemot JC; Coutard B; Decroly E
Rev Med Virol; 2020 Nov; 30(6):1-10. PubMed ID: 32779326
[TBL] [Abstract][Full Text] [Related]
18. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
Verma AK; Aggarwal R
Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing approach to fight COVID-19.
Singh TU; Parida S; Lingaraju MC; Kesavan M; Kumar D; Singh RK
Pharmacol Rep; 2020 Dec; 72(6):1479-1508. PubMed ID: 32889701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
